title: Chemotherapy of biliary tract cancer with mitomycin-C and 5-fluorouracil biologically modulated by folinic acid. A phase II study.
authors.forename: A
authors.initials: A
authors.lastname: Polyzos
authors.forename: G
authors.initials: G
authors.lastname: Nikou
authors.forename: A
authors.initials: A
authors.lastname: Giannopoulos
authors.forename: A
authors.initials: A
authors.lastname: Toskas
authors.forename: N
authors.initials: N
authors.lastname: Kalahanis
authors.forename: J
authors.initials: J
authors.lastname: Papargyriou
authors.forename: P
authors.initials: P
authors.lastname: Michail
authors.forename: A
authors.initials: A
authors.lastname: Papachristodoulou
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001661:Biliary Tract Neoplasms / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004347:Drug Interactions; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage
chemical_list: D016685:Mitomycin; D002955:Leucovorin; D005472:Fluorouracil